Correlation between endogenous polyamines in human cardiac tissues and clinical parameters in patients with heart failure

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 2, 2016, Pages 302-312

  Meana, Clara ^a   Rubín, José Manuel ^b   Bordallo, Carmen ^c   Suárez, Lorena ^c   Bordallo, Javier ^a,c   Sánchez, Manuel ^a,c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Atria; Cyclic AMP; Heart; Heart failure; N1 acetylpolyamine oxidase; Ornithine decarboxylase; Polyamines; Putrescine; Spermidine; Spermine

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE; ISOAMYLAMINE; N1 ACETYLPOLYAMINE OXIDASE; N1 ACETYLSPERMIDINE; ORNITHINE DECARBOXYLASE; POLYAMINE DERIVATIVE; PUTRESCINE; RNA 18S; SPERMIDINE; UNCLASSIFIED DRUG; N(1)-ACETYLPOLYAMINE OXIDASE, HUMAN; OXIDOREDUCTASE; POLYAMINE;

ADULT; AGED; ARTICLE; BIOCHEMICAL ANALYSIS; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; HEART ATRIUM APPENDAGE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; NEW YORK HEART ASSOCIATION CLASS; POLYAMINE METABOLISM; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEPTAL WALL THICKNESS; CARDIAC MUSCLE; HEART; HEART RATE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEART; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYAMINES;

EID: 84955742358     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12674     Document Type: Article

References (63)

1. Moinard C, Cynober L, de Bandt JP. Polyamines: metabolism and implications in human diseases. Clin Nutr. 2005; 24: 184-97.
2. Igarashi K, Kashiwagi K. Characteristics of cellular polyamine transport in prokaryotes and eukaryotes. Plant Physiol Biochem. 2010; 48: 506-12.
3. Seiler N, Raul F. Polyamines and apoptosis. J Cell Mol Med. 2005; 9: 623-42.
4. Koenig H, Fan CC, Goldstone AD, et al. Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. Circ Res. 1989; 64: 415-26.
5. Fan CC, Koenig H. The role of polyamines in beta-adrenergic stimulation of calcium influx and membrane transport in rat heart. J Mol Cell Cardiol. 1988; 20: 789-99.
6. Bordallo C, Cantabrana B, Velasco L, et al. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat. Eur J Pharmacol. 2008; 598: 68-74.
7. Bordallo C, Rubin JM, Varona AB, et al. Increases in ornithine decarboxylase activity in the positive inotropism induced by androgens in isolated left atrium of the rat. Eur J Pharmacol. 2001; 422: 101-7.
8. 2+]i homeostasis and contractility in isolated rat ventricular cardiomyocytes. Am J Physiol. 1994; 267: H587-92.
9. Sanchez M, Secades L, Bordallo C, et al. Role of polyamines and cAMP-dependent mechanisms on 5alpha-dihydrotestosterone-elicited functional effects in isolated right atria of rat. J Cardiovasc Pharmacol. 2009; 54: 310-8.
10. Nilsson BO, Gomez M, Santiago Carrilho R, et al. Differential actions of exogenous and intracellular spermine on contractile activity in smooth muscle of rat portal vein. Acta Physiol Scand. 1995; 154: 355-65.
11. Sward K, Dreja K, Hellstrand P. Contractile effects of polycations in permeabilized smooth muscle. J Muscle Res Cell Motil. 1998; 19: 463-72.
12. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal. 1997; 9: 1-13.
13. Fu LY, Cummins TR, Moczydlowski EG. Sensitivity of cloned muscle, heart and neuronal voltage-gated sodium channels to block by polyamines: a possible basis for modulation of excitability in vivo. Channels. 2012; 6: 41-9.
14. Huang CJ, Moczydlowski E. Cytoplasmic polyamines as permeant blockers and modulators of the voltage-gated sodium channel. Biophys J. 2001; 80: 1262-79.
15. Velasco L, Secades L, Bordallo C, et al. Role of putrescine on androgen-elicited positive inotropism in the left atrium of rats. J Cardiovasc Pharmacol. 2008; 52: 161-6.
16. Meana C, Bordallo J, Bordallo C, et al. Functional effects of polyamines via activation of human beta1- and beta2-adrenoceptors stably expressed in CHO cells. Pharmacol Rep. 2010; 62: 696-706.
17. Flamigni F, Stefanelli C, Guarnieri C, et al. Modulation of ornithine decarboxylase activity and ornithine decarboxylase-antizyme complex in rat heart by hormone and putrescine treatment. Biochim Biophys Acta. 1986; 882: 377-83.
18. Tipnis UR, He GY, Li S, et al. Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis. Cardiovasc Pathol. 2000; 9: 273-80.
19. Feldman MJ, Russell DH. Polyamine biogenesis in left ventricle of the rat heart after aortic constriction. Am J Physiol. 1972; 222: 1199-203.
20. Cubria JC, Reguera R, Balana-Fouce R, et al. Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse. J Pharm Pharmacol. 1998; 50: 91-6.
21. Caldarera CM, Casti A, Rossoni C, et al. Polyamines and noradrenaline following myocardial hypertrophy. J Mol Cell Cardiol. 1971; 3: 121-6.
22. Larson DF, Copeland JG, Russell DH. Catecholamine-induced cardiac hypertrophy in a denervated, hemodynamically non-stressed heart transplant. Life Sci. 1985; 36: 2477-89.
23. Shantz LM, Feith DJ, Pegg AE. Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. Biochem J. 2001; 358: 25-32.
24. Giordano E, Hillary RA, Vary TC, et al. Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy. Amino Acids. 2012; 42: 507-18.
25. Metcalf BW, Bey P, Danzin C, et al. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.G. 4.1.1.17) by substrate and product analogues. J Am Chem Soc. 1978; 100: 2551-3.
26. Bartolome J, Huguenard J, Slotkin TA. Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science. 1980; 210: 793-4.
27. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28: 1-39, e14.
28. Lau C, Slotkin TA. Regulation of rat heart ornithine decarboxylase: change in affinity for ornithine evoked by neuronal, hormonal, and ontogenetic stimuli. Mol Pharmacol. 1979; 16: 504-12.
29. Hayashi T, Nagayama K, Arisawa M, et al. Pentagalloylglucose, a xanthine oxidase inhibitor from a Paraguayan crude drug, "Molle-i" (Schinus terebinthifolius). J Nat Prod. 1989; 52: 210-1.
30. Escribano MI, Legaz ME. High performance liquid chromatography of the dansyl derivatives of putrescine, spermidine, and spermine. Plant Physiol. 1988; 87: 519-22.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-9.
32. Kaiser H. An index of factorial simplicity. Psychometrika. 1974; 39: 31-6.
33. Bartlett MS. A note on the multiplying factors for various chi square approximations. J Roy Stat Soc. 1954; 16: 296-8.
34. Thurstone LL. Multiple factor analysis. Chicago, IL: University of Chicago Press; 1947.
35. Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2071-94.
36. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J. 2003; 376: 1-14.
37. Matsui I, Wiegand L, Pegg AE. Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J Biol Chem. 1981; 256: 2454-9.
38. Tjandrawinata RR, Byus CV. Regulation of the efflux of putrescine and cadaverine from rapidly growing cultured RAW 264 cells by extracellular putrescine. Biochem J. 1995; 305: 291-9.
39. Schluter KD, Frischkopf K, Flesch M, et al. Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy. Cardiovasc Res. 2000; 45: 410-7.
40. Zhao YJ, Xu CQ, Zhang WH, et al. Role of polyamines in myocardial ischemia/reperfusion injury and their interactions with nitric oxide. Eur J Pharmacol. 2007; 562: 236-46.
41. Zhao YJ, Zhang WH, Xu CQ, et al. Involvement of the ornithine decarboxylase/polyamine system in precondition-induced cardioprotection through an interaction with PKC in rat hearts. Mol Cell Biochem. 2009; 332: 135-44.
42. Chirino-Galindo G, Mejia-Zepeda R, Palomar-Morales M. Change in lipoperoxidation but not in scavenging enzymes activity during polyamine embryoprotection in rat embryo cultured in hyperglycemic media. In Vitro Cell Dev Biol Anim. 2012; 48: 570-6.
43. Yoshida M, Tomitori H, Machi Y, et al. Acrolein toxicity: comparison with reactive oxygen species. Biochem Biophys Res Commun. 2009; 378: 313-8.
44. Choi YH, Park HY. Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells. J Biomed Sci. 2012; 19: 31.
45. Giordano E, Flamigni F, Guarnieri C, et al. Polyamines in cardiac physiology and disease. Open Heart Failure Journal. 2010; 3: 25-30.
46. Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J. 2009; 421: 323-38.
47. Sag CM, Santos CX, Shah AM. Redox regulation of cardiac hypertrophy. J Mol Cell Cardiol. 2014; 73: 103-11.
48. Kohler AC, Sag CM, Maier LS. Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology. J Mol Cell Cardiol. 2014; 73: 92-102.
49. Schluter KD, Schulz R, Schreckenberg R. Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart. Front Physiol. 2015; 6: 65.
50. Clo C, Tantini B, Coccolini MN, et al. Mediation of polyamine-induced decrease of cyclic AMP content by cyclic AMP-phosphodiesterase in chick heart cell cultures. J Mol Cell Cardiol. 1981; 13: 773-6.
51. Du XJ, Autelitano DJ, Dilley RJ, et al. Beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation. 2000; 101: 71-7.
52. Lefkowitz RJ, Rockman HA, Koch WJ. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation. 2000; 101: 1634-7.
53. Gainetdinov RR, Premont RT, Bohn LM, et al. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci. 2004; 27: 107-44.
54. Triposkiadis F, Karayannis G, Giamouzis G, et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009; 54: 1747-62.
55. Kishi T. Heart failure as an autonomic nervous system dysfunction. J Cardiol. 2012; 59: 117-22.
56. Melsom CB, Hussain RI, Orstavik O, et al. Non-classical regulation of beta1- and beta 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi. Naunyn Schmiedebergs Arch Pharmacol. 2014; 387: 1177-86.
57. Richter W, Day P, Agrawal R, et al. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4. EMBO J. 2008; 27: 384-93.
58. Nikolaev VO, Moshkov A, Lyon AR, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science. 2010; 327: 1653-7.
59. Conti M, Mika D, Richter W. Cyclic AMP compartments and signaling specificity: role of cyclic nucleotide phosphodiesterases. J Gen Physiol. 2014; 143: 29-38.
60. Mika D, Bobin P, Pomerance M, et al. Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes. Cardiovasc Res. 2013; 100: 336-46.
61. Mika D, Leroy J, Vandecasteele G, et al. PDEs create local domains of cAMP signaling. J Mol Cell Cardiol. 2012; 52: 323-9.
62. Liberles SD. Trace amine-associated receptors: ligands, neural circuits, and behaviors. Curr Opin Neurobiol. 2015; 34C: 1-7.
63. Wang R, Xu C, Zhao W, et al. Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem. 2003; 270: 2680-8.